EONE continues its efforts to serve as a leader
of the medical science of the future
| Test Code | Test item | Specimen | Test Schedule | analytic time |
|---|---|---|---|---|
| H0084 | Drug test | Serum | Mon-Fri | 15 days |
| B2023 | Du Test | WB(EDTA) | Mon-Sat | 1 day |
| D7004 | Duloxetine | Serum | Fri | 21 days |
| A0060 | DUPAN-2 | Serum | Tue,Fri | 20 days |
| H0894 | DYSF gene, mutation (Miyoshi myopathy, LGMD2B) | WB(EDTA) | Mon-Thu | 4 weeks |
| B3081 | Dyshemoglobin Test | WB(EDTA) | Mon-Sat | 1 day |
| B11142 | Dysmorphic RBC | Urine | Mon-Sat | 1 day |
| IHC041 | E-cadherin (IHC) | Paraffin Block | Mon-Fri | 3 days |
| B4113 | E.coli O157 culture | Stool | Mon-Sat | 5 days |
| B4113 | E.coli O157 culture | Rectal swab | Mon-Sat | 5 days |
| B4113 | E.coli O157 culture | other | Mon-Sat | 5 days |
| C468244 | EBV EA-DR IgG | Serum | Mon-Fri | 1 day |
| C468244 | EBV EA-DR IgG | CSF | Mon-Fri | 1 day |
| C468344 | EBV EA-DR IgM | Serum | Wed,Fri | 1 day |
| C468245 | EBV EBNA IgG | Serum | Mon-Fri | 1 day |
| C468245 | EBV EBNA IgG | CSF | Mon-Fri | 1 day |
| H0815 | EBV in situ hybridization | other | Mon-Thu | 5 days |
| P7001 | EBV in situ hybridization | Paraffin Block | Mon-Fri | 3 days |
| C5955 | EBV PCR | Serum | Mon,Wed,Fri | 2 days |
| C5955 | EBV PCR | WB(EDTA) | Mon,Wed,Fri | 2 days |